Announcements 2024

Peania, 14 February 2024 - Lavipharm S.A., in accordance with Regulation (EU) 596/2014, announces the cessation of the Group’s pharmaceutical wholesale activities and logistics services to third parties (3PL), and the transfer of certain assets of its subsidiary LAS to Profarm S.A. Special attention has...